NCT00046332 - A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions

HIV Infections

Interventions

DRUG

GW810781

Trial Locations (23)

10008

GSK Clinical Trials Call Center, New York

10011

GSK Clinical Trials Call Center, New York

10032

GSK Clinical Trials Call Center, New York

10461

GSK Clinical Trials Call Center, The Bronx

20007

GSK Clinical Trials Call Center, Washington D.C.

27599

GSK Clinical Trials Call Center, Chapel Hill

27710

GSK Clinical Trials Call Center, Durham

28203

GSK Clinical Trials Call Center, Charlotte

30308

GSK Clinical Trials Call Center, Atlanta

32701

GSK Clinical Trials Call Center, Altamonte Springs

33133

GSK Clinical Trials Call Center, Miami

33311

GSK Clinical Trials Call Center, Fort Lauderdale

33614

GSK Clinical Trials Call Center, Tampa

46202

GSK Clinical Trials Call Center, Indianapolis

55404

GSK Clinical Trials Call Center, Minneapolis

75235

GSK Clinical Trials Call Center, Dallas

77004

GSK Clinical Trials Call Center, Houston

80220

GSK Clinical Trials Call Center, Denver

85006

GSK Clinical Trials Call Center, Phoenix

90048

GSK Clinical Trials Call Center, Los Angeles

90069

GSK Clinical Trials Call Center, West Hollywood

92103

GSK Clinical Trials Call Center, San Diego

94115

GSK Clinical Trials Call Center, San Francisco